Mycosis fungoides secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Mycosis fungoides}} | {{Mycosis fungoides}} | ||
{{CMG}} | {{CMG}} {{AE}} {{S.G.}} | ||
==Overview== | ==Overview== |
Revision as of 03:56, 11 February 2019
Mycosis fungoides Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Mycosis fungoides secondary prevention On the Web |
American Roentgen Ray Society Images of Mycosis fungoides secondary prevention |
Risk calculators and risk factors for Mycosis fungoides secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]
Overview
There are no established measures for the secondary prevention of mycosis fungoides.
Secondary Prevention
- There are no established measures for the secondary prevention of mycosis fungoides
- Effective measures for the secondary prevention of mycosis fungoides include:[1]
- Prevention of skin infections (observe every 4-6 weeks)
- Phototherapy (PUVA and involves oral 8-methoxypsoralen) is the preservation in the early stage.